Public advocacy by the Roman Catholic Church and the United States Conference of Catholic Bishops in the twenty-first century

The Roman Catholic Church has engaged in moral criticism throughout history and continues to do so today through movie reviews published by the United States Conference of Catholic Bishops (USCCB). The history of the Roman Catholic Church\u27s censorship of moral content includes controlling the amount and type of media available. This rhetorical analysis of both the USCCB and New York Times movie reviews for the top ten grossing movies of 2006 discusses rhetoric as an expression of meaning that emerges through a texts\u27 historical and cultural situation. Both sets of reviews are found on the Internet and this analysis argues that they contribute to the Roman Catholic Church\u27s ongoing attempts to influence morality in the absence of moral criticism in popular culture media

Absorption of Impact Forces by Three Types of Equestrian Protective Vests

Please view abstract in the attached PDF file

New advances in radiomics of gastrointestinal stromal tumors

Gastrointestinal stromal tumors (GISTs) are uncommon neoplasms of the gastrointestinal tract with peculiar clinical, genetic, and imaging characteristics. Preoperative knowledge of risk stratification and mutational status is crucial to guide the appropriate patients’ treatment. Predicting the clinical behavior and biological aggressiveness of GISTs based on conventional computed tomography (CT) and magnetic resonance imaging (MRI) evaluation is challenging, unless the lesions have already metastasized at the time of diagnosis. Radiomics is emerging as a promising tool for the quantification of lesion heterogeneity on radiological images, extracting additional data that cannot be assessed by visual analysis. Radiomics applications have been explored for the differential diagnosis of GISTs from other gastrointestinal neoplasms, risk stratification and prediction of prognosis after surgical resection, and evaluation of mutational status in GISTs. The published researches on GISTs radiomics have obtained excellent performance of derived radiomics models on CT and MRI. However, lack of standardization and differences in study methodology challenge the application of radiomics in clinical practice. The purpose of this review is to describe the new advances of radiomics applied to CT and MRI for the evaluation of gastrointestinal stromal tumors, discuss the potential clinical applications that may impact patients’ management, report limitations of current radiomics studies, and future directions

A single amino acid change A19V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia?

We screened 100 children with acute lymphoblastic leukemia (ALL) to assess the incidence of single amino acid change A91V in perform. Heterozygous A91V was found in 12/100 patients and 5/127 controls (OR, 3.4; 95%CI: 1.15-9.95; p=0.014). A91V is a novel and frequent predisposing factor for childhood ALL

Extracting the three- and four-graviton vertices from binary pulsars and coalescing binaries

Using a formulation of the post-Newtonian expansion in terms of Feynman graphs, we discuss how various tests of General Relativity (GR) can be translated into measurement of the three- and four-graviton vertices. In problems involving only the conservative dynamics of a system, a deviation of the three-graviton vertex from the GR prediction is equivalent, to lowest order, to the introduction of the parameter beta_{PPN} in the parametrized post-Newtonian formalism, and its strongest bound comes from lunar laser ranging, which measures it at the 0.02% level. Deviation of the three-graviton vertex from the GR prediction, however, also affects the radiative sector of the theory. We show that the timing of the Hulse-Taylor binary pulsar provides a bound on the deviation of the three-graviton vertex from the GR prediction at the 0.1% level. For coalescing binaries at interferometers we find that, because of degeneracies with other parameters in the template such as mass and spin, the effects of modified three- and four-graviton vertices is just to induce an error in the determination of these parameters and, at least in the restricted PN approximation, it is not possible to use coalescing binaries for constraining deviations of the vertices from the GR prediction.Comment: 10 pages, 5 figures; v2: an error corrected; references adde

Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI

Hepatocellular carcinoma (HCC) may have an infiltrative appearance in about 8–20% of cases. Infiltrative HCC can be a challenging diagnosis and it is associated with the worst overall survival among HCC patients. Infiltrative HCC is characterized by the spread of multiple minute nodules throughout the liver, without a dominant one, ultimately resulting into macrovascular invasion. On CT and MRI, infiltrative HCC appears as an ill-defined, large mass, with variable degree of enhancement, and satellite neoplastic nodules in up to 52% of patients. On MRI, it may show restriction on diffusion weighted imaging, hyperintensity on T2- and hypointensity on T1-weighted images, and, if hepatobiliary agent is used, hypointensity on hepatobiliary phase. Infiltrative HCC must be differentiated from other liver diseases, such as focal confluent fibrosis, steatosis, amyloidosis, vascular disorders of the liver, cholangiocarcinoma, and diffuse metastatic disease. In cirrhotic patients, the identification of vascular tumor invasion of the portal vein and its differentiation from bland thrombosis is of utmost importance for patient management. On contrast enhanced CT and MRI, portal vein tumor thrombosis appears as an enhancing thrombus within the portal vein, close to the main tumor and results into vein enlargement. The aim of this pictorial review is to show CT and MRI features that allow the diagnosis of infiltrative HCC and portal vein tumor thrombosis. A particular point of interest includes the tips and tricks for differential diagnosis with potential mimickers of infiltrative HCC

Design and Overview of the Solar Cruiser Mission

Solar Cruiser is a Small Satellite Technology Demonstration Mission (TDM) of Opportunity to mature solar sail propulsion technology to enable near-term, high-priority breakthrough science missions as defined in the Solar and Space Physics Decadal Survey. Solar Cruiser will demonstrate a “sailcraft” platform with pointing control and attitude stability comparable to traditional platforms, upon which a new class of Heliophysics missions may fly instruments. It will show sailcraft operation (acceleration, navigation, station keeping, inclination change) immediately applicable to near-term missions, and show scalability of sail technologies such as the boom, membrane, deployer, reflectivity control devices for roll momentum management to enable more demanding missions, such as high inclination solar imaging. A team led by the NASA Marshall Space Flight Center is developing the Solar Cruiser with partners Ball Aerospace and Roccor (a Redwire company). Ball is responsible for procuring a Venus class microsat commercial bus from Blue Canyon Technologies, defining all necessary mission-specific modifications, and performing the Integration and Test of the Bus with the Solar Sail System to form the completed sailcraft. Ball will also procure the IRIS radio from Space Dynamics Laboratories and develop the adapter and harnessing that interfaces to the Launch Vehicle. Roccor will integrate the Solar Sail System (SSS), including the sail membrane from their Subcontractor NeXolve, the Triangular, Rollable and Collapsible (TRACTM) Boom, the LISAs (Lightweight Integrated Solar Arrays) and momentum management Reflective Control Devices (RCDs), before providing it to Ball for Integration and Test. Roccor will also build the Active Mass Translator (AMT), which moves the Sail relative to the Bus to control momentum in the pitch/yaw directions, while the RCDs provide roll control. MSFC manages the overall mission and provide the specialized solar sail attitude determination and control system (SSADCS) algorithms and software necessary to fly the sailcraft. The SSADCS software created for this mission will autonomously operate the AMT and RCDs to provide complete momentum control of the sailcraft. Bus-mounted Electric Propulsion thrusters are included to provide auxiliary momentum management, if required. Solar Cruiser will launch as a secondary payload with NASA’s Interstellar Mapping and Acceleration Probe (IMAP)in early 2025. The sailcraft will separate from the launch vehicle on a near-L1 trajectory (Sun-Earth Lagrangian Point 1; sunward of L1 along the Sun-Earth Line) and complete its primary mission in 11 months or less. During this time, Solar Cruiser will complete and fully characterize a large solar sail deployment (1,653 square meters/17,793 square feet), sail operation, station keeping in a sub-L1 halo orbit, inclination changes, and a roll demonstration. This paper provides a mission and sailcraft design overview, including objectives and planned operations of the technology demonstration mission. It presents the latest findings from technology maturation efforts, major program design reviews, and initial launch integration planning

Canine Mesenchymal Stem Cells from visceral and subcutaneuous adipose tissue for cell-based therapy

This study compared some characteristics of canine Adipose tissue-Derived Mesenchymal Stem Cells (cAD-MSCs) from subcutaneous and visceral fat. These findings were directed to obtain high quantity and quality cAD-MSCs for clinical cell-based therapy